newsfilter
← Latest News
GlobeNewswire·

Belite Bio to Participate in the Leerink Global Healthcare Conference

SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative